A Stepwise Approach To Acute Dry Eye
How to approach the occasional situation in which this chronic condition suddenly becomes acute.
Identifying and Filling the Unmet Need
Ophthalmic Product Development Insights
Quarterly Ora Newsletter - May 1, 2015
Customer Success Stories: Celebrating Your Big Wins in 2014-2015
Mitotech Announces Phase 2 Data Showing Positive Effect of SkQ1 in Patients with Dry Eye Syndrome
SkQ1 is the first mitochondria-targeted antioxidant to reach clinical phase of development for an ophthalmic indication
RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S.
U.S. joint venture with G-treeBNT (ReGenTree LLC) has retained Ora, Inc.
The Logistics of Participating in Device Clinical Trials
Communication and proper preparation are necessary for a successful study.
Gene Therapy for Retinal Diseases
The eye is an ideal target for gene therapy.
Clinical Advances in Ocular Allergy
Researchers
are exploring
disease-modifying
treatment options
and not just
symptomatic relief.
Hopes and Hurdles for Stem Cell Therapy
The exciting world of stem cell therapy is the cutting edge of
medical research. Here’s how it intersects with ophthalmology.